Exhaustive Covid-19 vaccine delivery plan will be unveiled once clinical trials are completed: Tamil Nadu Health Dept

▴ Exhaustive Covid-19 vaccine delivery plan will be unveiled once clinical trials are completed: Tamil Nadu Health Dept
The Tamil Nadu Health Department has said an exhaustive Covid-19 vaccine delivery plan will be unveiled once their clinical trials are completed.

The Tamil Nadu Health Department has said an exhaustive Covid-19 vaccine delivery plan will be unveiled once their clinical trials are completed.

Meanwhile, the state witnessed 1,688 new cases yesterday, and the active caseload has dipped further to 13,404.
 

In Chennai, clinical trials of two vaccines are currently underway, as approved by the Indian Council for Medical Research. The Covishield, developed by Oxford University and the pharma major AstraZeneca, and Bharat Biotech’s Covaxin are the two vaccine candidates that are undergoing field trials in Chennai.

 
The state health minister Dr. Vijayabhaskar told reporters in Chennai yesterday that once the trials are over and the Union Government gives the go-ahead, the delivery mechanism will be put in place to cover the population in the state.

He urged the public to continue to wear masks and follow social distancing.

Tags : #India #TamilNadu #StateGovernment #HealthDepartment #Covid19Vaccine #ClinicalTrials #Covishield #DrVijayabhaskar #AstraZeneca #BharatBiotech

About the Author


Rohit Sharma

Writer, Health Enthusiast, and an Accountant, Rohit Sharma is a writer at medicircle, penning down his thoughts about healthcare research, innovations, trends in healthcare and simply all about healthcare. Write to rohit on [email protected]

Related Stories

Loading Please wait...
-Advertisements-


Trending Now

1,031 new cases of COVID-19 confirmed in Himachal PradeshNovember 25, 2020
Cooking with wood may cause lung damageNovember 25, 2020
More than 56 lakh sample tests for COVID-19 conducted in OdishaNovember 25, 2020
COVID-19 recovery rate in Bihar improves to 97.30 pctNovember 25, 2020
Green Mediterranean (‘green Med’) diet may be even better for healthNovember 25, 2020
Chhattisgarh: Intensive Covid screening of all passengers to be done mandatorily at airportsNovember 25, 2020
New guidance issued on policies to protect populations in vulnerable situations in context of COVID-19November 25, 2020
Life Extension® Launches Bloat Relief Formula.November 25, 2020
Todos Medical Completes Installation of Lab Automation Equipment at Wisconsin Lab Client to Support COVID-19 PCR TestingNovember 25, 2020
Bristol Myers Squibb Receives European Commission Approval for OpdivoNovember 25, 2020
QualTex Laboratories adds Ortho Diagnostics VITROS® Anti-SARS-CoV-2 IgG assayNovember 25, 2020
China resorts to rigorous measures after multiple locally transmitted coronavirus cases detected in three citiesNovember 25, 2020
National COVID-19 recovery rate reaches 93.72 pctNovember 25, 2020
Nearly 11,60,000 COVID samples tested in country in last 24 hoursNovember 25, 2020
Lokelma label update approved in China for patients with hyperkalaemia on chronic haemodialysisNovember 25, 2020
Taking the Pill may cut risk of severe asthma bouts in women of reproductive ageNovember 25, 2020
Multilateral cooperation is key to overcoming global challenges such as COVID-19: Dr Harsh VardhanNovember 25, 2020
Polaryx Therapeutics receives both rare pediatric disease and orphan drug designations from US FDANovember 25, 2020
Panaxia and Neuraxpharm expand strategic collaboration to France with medical cannabisNovember 25, 2020
6,224 new cases of COVID-19 detected in DelhiNovember 25, 2020